Pasithea Therapeutics Chairman, Prof. Lawrence Steinman to Receive Pioneer in Medicine Award

February 16, 2023

https://www.globenewswire.com/news-release/2023/02/16/2609605/0/en/Pasithea-Therapeutics-Chairman-Prof-Lawrence-Steinman-to-Receive-Pioneer-in-Medicine-Award.html

PALO ALTO, Calif. and MIAMI, Fla., Feb. 16, 2023 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (NASDAQ:KTTA) (“Pasithea” or the “Company”), a biotechnology company focused on the discovery, research, and development of innovative treatments for Central Nervous System (CNS) disorders, today announced that Prof. Lawrence Steinman, Pasithea’s Chairman and National Academy of Sciences Professor, will receive the 2023 Pioneer in Medicine Award at the 20th Annual Gathering for the Cure on February 17 as part of the 20th Annual World Congress of SBMT.

Read more at globenewswire.com

Related news for (KTTA)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.